(Q37577926)

21 August 2017

1 reference

title

Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients (English)

1 reference

21 August 2017

1 reference

Athanassios Kyrgidis

1

1 reference

21 August 2017

Stefanos Triaridis

series ordinal

2

1 reference

21 August 2017

Kostantinos Vahtsevanos

series ordinal

3

1 reference

21 August 2017

Kostantinos Antoniades

series ordinal

4

1 reference

21 August 2017

language of work or name

1 reference

1 August 2009

1 reference

Expert Review of Anticancer Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

1125-1134

1 reference

21 August 2017

cites work

Cancer statistics, 2008

1 reference

Risks and benefits of bisphosphonates

21 January 2018

1 reference

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

21 January 2018

1 reference

Clinical features of metastatic bone disease and risk of skeletal morbidity

21 January 2018

1 reference

The role of bisphosphonates in breast cancer

21 January 2018

1 reference

Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference

21 January 2018

1 reference

Treatment of tumor-induced hypercalcemia: a solved problem?

21 January 2018

1 reference

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

21 January 2018

1 reference

Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer

21 January 2018

1 reference

Key roles of the OPG-RANK-RANKL system in bone oncology

21 January 2018

1 reference

Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.

21 January 2018

1 reference

Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients

21 January 2018

1 reference

Practical guidance for the management of aromatase inhibitor-associated bone loss

21 January 2018

1 reference

Bisphosphonates and bone metastases: current status and future directions

21 January 2018

1 reference

Cancer treatment-induced bone loss in breast and prostate cancer

21 January 2018

1 reference

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole

21 January 2018

1 reference

Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.

21 January 2018

1 reference

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

21 January 2018

1 reference

Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients

21 January 2018

1 reference

Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.

21 January 2018

1 reference

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

21 January 2018

1 reference

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy

21 January 2018

1 reference

Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients

21 January 2018

1 reference

Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

21 January 2018

1 reference

Clinical characterization might help in preventing osteonecrosis of the jaw.

21 January 2018

1 reference

Inhibition of oral mucosal cell wound healing by bisphosphonates.

21 January 2018

1 reference

Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis

21 January 2018

1 reference

Osteonecrosis of the jaw: who gets it, and why?

21 January 2018

1 reference

Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa

21 January 2018

1 reference

Impairment of gastric ulcer healing by alendronate, a nitrogen-containing bisphosphonate, in rats

21 January 2018

1 reference

Esophagitis associated with the use of alendronate

21 January 2018

1 reference

Reports of esophageal cancer with oral bisphosphonate use.

21 January 2018

1 reference

New molecular concepts of Barrett's esophagus: clinical implications and biomarkers.

21 January 2018

1 reference

Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

21 January 2018

1 reference

The role of macrophages in early healing of a tendon graft in a bone tunnel

21 January 2018

1 reference

Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients

21 January 2018

1 reference

Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells

21 January 2018

1 reference

Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease

21 January 2018

1 reference

Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells

21 January 2018

1 reference

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

21 January 2018

1 reference

The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells

21 January 2018

1 reference

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.

21 January 2018

1 reference

Zoledronate induces apoptosis in cells from fibro-cellular membrane of unicameral bone cyst (UBC).

21 January 2018

1 reference

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis

21 January 2018

1 reference

Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation

21 January 2018

1 reference

Fibroblast subpopulations in intra-oral wound healing

21 January 2018

1 reference

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

21 January 2018

1 reference

Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy

21 January 2018

1 reference

Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm.

21 January 2018

1 reference

Pathogenesis and natural history of osteonecrosis

21 January 2018

1 reference

Factors associated with osteonecrosis of the jaw among bisphosphonate users

21 January 2018

1 reference

Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

21 January 2018

1 reference

Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone

21 January 2018

1 reference

Bevacizumab-associated osteonecrosis of the jaw.

21 January 2018

1 reference

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

21 January 2018

1 reference

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.

21 January 2018

1 reference

Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?

21 January 2018

1 reference

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

21 January 2018

1 reference

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

21 January 2018

1 reference

The role of bone markers in metastatic bone disease

21 January 2018

1 reference

Potential new drug targets for osteoporosis

21 January 2018

1 reference

RANKL inhibition in the treatment of bone metastases

21 January 2018

1 reference

Comment on: Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients

21 January 2018

1 reference

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

21 January 2018

1 reference

Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'.

21 January 2018

1 reference

Keratinocyte-fibroblast interactions in wound healing

21 January 2018

1 reference

Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium.

21 January 2018

1 reference

Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4.

21 January 2018

1 reference

Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.

21 January 2018

1 reference

Cross-talk between fibroblast growth factor and bone morphogenetic proteins regulates gap junction-mediated intercellular communication in lens cells

21 January 2018

1 reference

Distribution of EGF and its receptor in growing red deer antler.

21 January 2018

1 reference

Growth factors and cytokines in wound healing

21 January 2018

1 reference

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.09.74

1 reference

21 August 2017

1 reference